NTRA
NASDAQ
$262.63
Natera Inc (NTRA)
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $282.14 (+7.43%)
Market Cap
$40B
Revenue 5Y CAGR
+40.96%
Free Cash Flow Yield
0.26%
Beta (5Y)
1.29
Price Chart
Valuation
Market Cap$40B
P/S15.61
P/B22.01
Profitability
Total Revenue (TTM)$2.50B
Gross Profit (TTM)$1.63B
EBITDA-$277M
Profit Margin-12.2%
Operating Margin-13.4%
EPS-$1.63
Financial Health
Debt-to-Equity4.5%
Free Cash Flow Yield0.26%
Growth & Risk
EPS 5Y CAGR-11.74%
Revenue 5Y CAGR+40.96%
Beta (5Y)1.29
Sharpe Ratio1.51